@lucas10mauriz shared with us via direct messaging recent publication from Nanda et all (Merck & Co) “Inhibition of N-nitrosamine Formation in Drug Product: A Model Study”, @leonardo.allain from Analytical science group is a contributor.
This article is a great compliment to the presentation that @ASrinivasan did for FDA at a recent Generic Drug Science and Research Initiative Public Workshop
Thankyou @lucas10mauriz@Naiffer_Host for sharing this Case study…
This will add a new perspective from the Formulation perspective as efforts as of now are more focussed on Excipients & their Risk Assessments.
Will read the document and revert back if there are any questions or thoughts from my end.